Structure Therapeutics (GPCR) Cash & Equivalents (2022 - 2026)
Quarterly Cash & Equivalents rose 77.02% to $1.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.5 billion through Mar 2026, up 77.02% year-over-year, with the annual reading at $799.6 million for FY2025, 8.65% down from the prior year.
Structure Therapeutics' Cash & Equivalents history spans 5 years, with the latest figure at $1.5 billion for Q1 2026.
- Cash & Equivalents came in at $1.5 billion for Q1 2026, up from $799.6 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $1.5 billion in Q1 2026 to a low of $26.1 million in Q4 2022.
- The 5-year median for Cash & Equivalents is $614.0 million (2024), against an average of $546.2 million.
- Year-over-year, Cash & Equivalents soared 2184.0% in 2024 and then tumbled 84.14% in 2025.
- Structure Therapeutics' Cash & Equivalents stood at $26.1 million in 2022, then skyrocketed by 397.46% to $129.8 million in 2023, then surged by 574.41% to $875.3 million in 2024, then dropped by 8.65% to $799.6 million in 2025, then skyrocketed by 82.4% to $1.5 billion in 2026.
- Per Business Quant, the three most recent readings for GPCR's Cash & Equivalents are $1.5 billion (Q1 2026), $799.6 million (Q4 2025), and $791.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 1.91 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 901.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 5.49 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.96 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.71 Bn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | 1.46 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.46 Bn |
| Dec 31, 2025 | 799.62 Mn |
| Sep 30, 2025 | 791.55 Mn |
| Jun 30, 2025 | 147.02 Mn |
| Mar 31, 2025 | 823.93 Mn |
| Dec 31, 2024 | 875.34 Mn |
| Sep 30, 2024 | 905.07 Mn |
| Jun 30, 2024 | 927.10 Mn |
| Mar 31, 2024 | 436.40 Mn |
| Dec 31, 2023 | 129.79 Mn |
| Sep 30, 2023 | 50.64 Mn |
| Jun 30, 2023 | 40.59 Mn |
| Mar 31, 2023 | 234.70 Mn |
| Dec 31, 2022 | 26.09 Mn |